ABBONDANZA, Ciro
 Distribuzione geografica
Continente #
EU - Europa 3.264
NA - Nord America 2.888
AS - Asia 598
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 6.757
Nazione #
US - Stati Uniti d'America 2.872
IT - Italia 994
IE - Irlanda 795
UA - Ucraina 359
GB - Regno Unito 292
CN - Cina 279
DE - Germania 263
FR - Francia 185
SG - Singapore 164
SE - Svezia 135
FI - Finlandia 109
TR - Turchia 91
GR - Grecia 57
KR - Corea 29
BE - Belgio 25
NL - Olanda 15
CA - Canada 14
IR - Iran 10
CH - Svizzera 8
HK - Hong Kong 7
AT - Austria 6
PK - Pakistan 6
IN - India 5
RO - Romania 5
AL - Albania 4
EU - Europa 4
HU - Ungheria 3
JP - Giappone 3
LT - Lituania 3
BR - Brasile 2
MX - Messico 2
AM - Armenia 1
AU - Australia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
IM - Isola di Man 1
KG - Kirghizistan 1
LU - Lussemburgo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 6.757
Città #
Dublin 795
Jacksonville 545
Chandler 534
Santa Clara 413
Ann Arbor 136
Caserta 122
Singapore 108
Princeton 100
Boardman 91
Bremen 91
Medford 72
Beijing 69
Roxbury 67
Cambridge 64
Rome 63
Woodbridge 62
Naples 61
Ashburn 42
San Mateo 42
Wilmington 41
Nanjing 40
Milan 39
Düsseldorf 29
Seoul 29
New York 27
Brussels 25
Munich 25
Venice 25
Nanchang 22
Des Moines 18
Bari 17
Helsinki 17
Napoli 17
Jinan 14
Shenyang 14
Mountain View 13
Auburn Hills 12
Kunming 12
Los Angeles 12
Pozzuoli 12
Norwalk 10
Tianjin 10
Aversa 9
Lanzhou 9
Hanover 8
Salerno 8
San Nicola la Strada 8
Cerami 7
Hebei 7
Hong Kong 7
Rockville 7
Zanjan 7
Bologna 6
Catania 6
Ferrara 6
Padova 6
Palermo 6
Poggiomarino 6
Shanghai 6
Casoria 5
Frattaminore 5
Haikou 5
Istanbul 5
Piedimonte San Germano 5
Stella Cilento 5
Boscotrecase 4
Buffalo 4
Caivano 4
Florence 4
Guangzhou 4
Hangzhou 4
Mazara Del Vallo 4
Ningbo 4
Perugia 4
Portland 4
Ragusa 4
Taiyuan 4
Taizhou 4
Verona 4
Vienna 4
Zhengzhou 4
Amsterdam 3
Andover 3
Atella 3
Bellinzona 3
Bergamo 3
Cava Dei Tirreni 3
Dearborn 3
Genoa 3
Kocaeli 3
Ottawa 3
Portici 3
Prato 3
Quartu Sant'elena 3
Sacramento 3
San Felice A Cancello 3
Santarcangelo di Romagna 3
Sciacca 3
Seattle 3
Tokyo 3
Totale 4.227
Nome #
Analisi delle sottopopolazioni linfocitarie nel trattamento cortisonico 445
Immunità innata: le prime linee di difesa 158
Immunobiologia di Janeway 128
Le basi dell'immunologia. Fisiopatologia del sistema immunitario 101
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 97
An aprotinin binding site localized in the hormone binding domain of the estrogen receptor from calf uterus 91
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 90
A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis 90
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 90
Studio dell’interazione tra il recettore dell’estradiolo e proteine di estratti nucleari da HeLa ed MCF-7 87
Regulation of p53 function in normal and malignant cells 84
17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells. 83
Induzione da acido retinoico (All-trans retinoico) della proteina RIZ 1, prodotto del gene oncosoppressore RIZ, in cellule di leucemia promielocitica 82
Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor 81
Estradiol receptor has proteolytic activity that is responsible for its own transformation 80
Aprotinin inhibits the hormone binding of the estrogen receptor from calf uterus 80
Antiproliferative effects of SOM 230 in EPN prostate cell line 80
Estradiol induces functional inactivation of p53 by intracellular redistribution 78
La capacità dell’ antioncogene p53 di legare specifiche sequenze di DNA è modulata in vitro dalla presenza di oligonucleotidi 78
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 77
In vitro binding of the purified hormone-binding subunit of the estrogen receptor to oligonucleotides containing natural or modified sequences of an estrogen-responsive element 75
Antibodies anti-p53 serological detection with ELISA method. 75
Meccanismi effettori dell’immunità umorale 74
L’acido all-trans retinoico e l’antiestrogeno ICI 182,780 promuovono apoptosi in cellule epiteliali estrogeno dipendenti (MCF-7) influenzando i livelli di Bcl-2 e p. 53 74
Proteolytic activity of the purified hormone-binding subunit of the estrogen receptor 73
Manifestazioni sistemiche dell'infiammazione (cap.16) 72
Anti-p53 antibodies detection in cancer patients. 72
ANTIPROLIFERATIVE EFFECTS OF SOM230 AND OCTREOTIDE IN EPN PROSTATE CELL LINE. 72
Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration. 71
Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells 71
ANTI-ONCOGENIC ACTION OF ESTRADIOL IN EPN, A NONTRANSFORMED PROSTATE EPITHELIAL CELL LINE: EFFECTS ON TUMOR SUPPRESSORS RB AND RIZ1 71
Rosacea and abatacept: the first report of a possible correlation 71
4) Purification of the estrogen receptor from calf uterus cytosol 70
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 69
Purified estrogen receptor enhances in vitro transcription 69
Proteomic analysis of MCF-7 cell lines expressing the zinc-finger or the proline-rich domain of retinoblastoma-interacting-zinc-finger protein 69
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 69
Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein 68
In vitro binding of the purified hormone-binding subunit of the estrogen receptor to the estrogen responsive element of the vitellogenin gene 68
Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein 67
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β 66
Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma 66
Identification of the Syrian hamster cardiomyopathy gene 66
Short 5’protuding oligonucleotides enhance binding of p53 to specific DNA sequences 66
Human PRDM2: Structure, function and pathophysiology 65
Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2 64
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription 64
Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies 63
Transcriptional control by nuclear receptor 63
Studio preliminare dell’espressione di TIM1, TIM3 e GITR sui linfociti T CD4+ di soggetti T- linfopenici e in terapia con interferone alfa 63
DNA strend breaks induce the formation of p53 protein stable complexes with p53 target site and modifyits protease sensitivity 63
Short 5’protuding oligonucleotides enhance binding of p53 to specific DNA sequences 62
Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell 61
Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation 61
Metal binding sites of the estradiol receptor from calf uterus and their possible role in the regulation of receptor function 61
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 61
PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation 60
Immunità Innata 60
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 59
Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein) 58
Immunità innata: le prime linee di difesa 58
Prostate cancer stem cells: the role of androgen and estrogen receptors. 58
Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues 56
Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues 56
Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells 56
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence 56
EXPRESSION AND CELLULAR LOCALIZATION OF TUMOR SUPPRESSOR PROTEIN RIZ1 (RETINOBLASTOMA-INTERACTING ZINC-FINGER PROTEIN 1) IN PROSTATE TISSUES. 56
INTERACTION OF ESTROGEN RECEPTOR α WITH THE RETINOBLASTOMA-INTERACTING-ZING-FINGER GENE PRODUCT RIZ 55
Serum anti-p53 antibodies and progression of hepatic diseases HCV related. 54
Mouse monoclonal antibodies against estrogen receptor 54
Differentiation of Myeloid cell lines correlates with a selective expression of RIZ protein 54
Retinoblastoma-Interacting Zinc-Finger protein (RIZ): un candidato tumor-suppressor effettore dell’azione degli estrogeni 54
Decreased serum vascular endothelial growth Factor-D (VEGF-D) levels in metastatic patients with differentiated thyroid carcinoma. 53
Identification and characterization of the protein product of the human homeotic gene c8 53
Piccoli oligonucleotidi attivano la funzione di p53 modificando la sua affinità per specifiche sequenze di DNA 53
Tumor suppressor protein RIZ1 expression is regulated by DHT in prostate epithelial cells 53
DIFFERENT EXPRESSION OF ESTROGEN RECEPTOR α AND β IN PRIMARY CULTURES OF NORMAL AND MALIGNANT HUMAN PROSTATE EPITHELIAL CELLS 53
Regolazione dell’espressione di p53 p21(WAF-1/CIP1) e di Bcl-2 da parte dell’estradiolo, dell’acido all-trans retinico e dell’ICI 182,780 in cellule di carcinoma mammario 52
ESTROGEN RECEPTOR α AND β EXPRESSION IN PRIMARY CULTURES OF NORMAL AND MALIGNANT PROSTATE EPITHELIAL CELLS . 52
The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action 51
The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation 51
Expression of PRDM1/BLIMP1 and PRDM2/RIZ in the activation of T CD4+ naïve limphocytes 51
Riz, Rb e p53, tre nuovi possibili markers dell’azione dell’estradiolo in cellule di carcinoma mammario 51
Pan-cancer mutational and transcriptional analysis of the integrator complex 50
Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework 49
ESPESSIONE DEL TUMOR SUPPRESSOR RIZ1 IN CELLULE EPITELIALI NORMALI E MALIGNE DI PROSTATA 49
A proteomic analysis of protein expression pattern of MCF-7 cell lines transfected with the zinc-finger and proline-rich domain of retinoblastoma-interacting zinc-finger protein 48
EXPRESSION OF RIZ1 TUMOR SUPPRESSOR IN NORMAL AND MALIGNANT PROSTATE EPITHELIAL CELLS 45
Estrogen Induces Looping Between Tumor Suppressor RIZ Gene Promoter 2 with Exon 9a 44
DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. 43
ESTROGEN RECEPTOR α and β EXPRESSION AND IMMUNOREACTIVITY IN NORMAL AND CANCER HUMAN PROSTATES 43
Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA. 43
Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines 43
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. 41
Oestrogenreceptor beta expression and immunoreacivity 41
PRDM Gene Products in Testicular Germ Cell Tumors 41
Multifaceted role of PRDM proteins in human cancer 39
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 38
Highlighting chromosome loops in DNA-picked chromatin (DPC) 32
PR/SET domain family and cancer: Novel insights from the cancer genome atlas 32
Totale 6.813
Categoria #
all - tutte 27.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 0 0 0 0 0 0 130 45 61 58 46 9
2020/2021910 77 14 102 58 159 20 126 95 23 122 86 28
2021/2022795 57 17 15 39 242 10 15 17 25 66 72 220
2022/20231.836 169 64 26 185 187 156 17 128 806 23 39 36
2023/2024814 77 34 48 100 186 64 38 48 18 22 63 116
2024/2025786 15 56 48 119 285 260 3 0 0 0 0 0
Totale 6.933